Editorial Volume 22 Issue 2 - 2026

The Novel Paradigm for a Medicine Personalized for a Wider Preventive Measure for Women's Health

Maria Luigia Pallotta*

Department Medicine and Health Sciences, Molise University, Italy

*Corresponding Author: Maria Luigia Pallotta, Department Medicine and Health Sciences, Molise University, Italy.
Received: January 12, 2026; Published: January 26, 2026



A new age for cancer therapy has been inaugurated for assisting the medical community in a novel approach on 4P Medicine (viz Personalized, Predictive, Preventive and Participatory) [1-3]. Artificial intelligence (AI) is rapidly reshaping cancer research and personalized clinical care.

  1. Pallotta ML. The Aquarian Age in cancer therapy: biobankers, biomarkers, and much more↔getting of the root of the problem ↔NAD+an ancient metabolite with surprising modernity ↔Mitochondrial NAD pool, tumour microenvironment and metastasis”. Cell Symposia, Multifaceted Mitochondria, Chicago (2015).
  2. Pallotta ML. Boosting NAD(P)+biosynthesis with NAD(P)+intermediates and monitoring mitochondrial NAD(P)+/NAD(P)H pool by means of Fluorescence-Based techniques could be a strategy for preventing and treating Woman’s Cancers. FEBS Berlin (2015).
  3. Pallotta ML. “Monitoring NAD(P)H levels and their relevance to bioenergetics using Fluorescence-Based Strategies in salivary samples: a possible biomarker in the detection of cancer and precancer”. EUSTM on New Horizons in Translational (2016).

Maria Luigia Pallotta. “The Novel Paradigm for a Medicine Personalized for a Wider Preventive Measure for Women's Health”. EC Microbiology  22.2 (2026): 01.